🏛️ Verified NIH Protocol • Sourced via U.S. National Library of Medicine (Last Synced: 2026-04-15)

Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System

🟢 Recruiting Protocol / Phase N/A ⚙️ Medical Device Protocol Sponsor: Pulse Biosciences, Inc.

🩺 Protocol Summary

The primary objective of this study is to reproduce in a multi-center study results obtained during the feasibility First-In-Human (FIH) study with Prof. Stefano Spiezia, MD (Ospedale del Mare, Naples, Italy) and to monitor additional thyroid-related symptoms and impact of patients quality of life post-ablation using a validated QoL questionnaire.

Primary Research Facility: Sarasota Memorial Hospital (Sarasota, Florida)

📋 Basic Study Criteria & Logistics Checklist

0 of 3 Checked

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Thyroid Nodule?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged between 22 Years and 80 Years?

🔍 Protocol Specified Age Range: 22 Years to 80 Years

Able to attend required in-person clinic visits and study procedures at one of the participating study centers?

🔍 Logistical Requirement: 3 Registered Participating Sites

📍 Primary Site Map

Site: Sarasota Memorial Hospital — Sarasota, Florida

📍 All Participating Trial Locations (3 Sites)

Multi-Center Trial

This protocol is enrolling participants across multiple clinical centers:

1. Sarasota Memorial Hospital — Sarasota, Florida • Contact: (941) 917-1299

2. NYU Langone Health — New York, New York

3. Weill Cornell Medicine — New York, New York

📄 Print Doctor Discussion Sheet

Preview and print a 1-page summary with 5 tailored questions for your physician.

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.

🏛️ Official Government Provenance

NIH ClinicalTrials.gov Protocol Record

NCT Identifier: NCT07287176 • Last Synced: 2026-04-15

View on ClinicalTrials.gov ↗